Search
Search Results
##search.searchResults.foundPlural##
-
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3088PDF: 1371HTML: 5830Fig1-Ag-Pil: 191Ag-Pil Fig.2: 194 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3096PDF: 1005HTML: 411 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2523PDF: 1026HTML: 94 -
IMMUNOLOGICAL EVOLUTION OF A COHORT OF HIV-2 INFECTED PATIENTS: PECULIARITIES OF AN UNDERESTIMATED INFECTION HIV-2 INFECTED PATIENTS PECULIARITIES
921PDF: 578HTML: 210 -
-
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
3663PDF: 3019HTML: 181 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2146PDF: 920HTML: 1867 -
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
1949PDF: 759HTML: 1022 -
AN INEXPENSIVE CLINICAL-LABORATORY NOMOGRAM TO PREDICT POST-TREATMENT LUNG DESTRUCTION IN PULMONARY TUBERCULOSIS
435PDF: 176Suppl. Files: 41Html: 29 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1334PDF: 704HTML: 189 -
ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS: PREDICTIVE PARAMETERS Anorectal pathologies in leukemias
1116PDF: 673Html: 77 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1077PDF: 578HTML: 6780 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2423PDF: 804HTML: 8784Efremov 1: 204Efremov 2: 161 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2009PDF: 823HTML: 288 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1230PDF: 974HTML: 105 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
3948PDF: 1003HTML: 3552Untitled: 162Cneo. Fig.1: 96Untitled: 87Untitled: 109Untitled: 110 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1318PDF: 782HTML: 3100 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3638PDF: 1404HTML: 455Figures . Eliassian: 198 -
HEMATOLOGICAL ABNORMALITIES BEYOND LYMPHOCYTOSIS DURING INFECTIOUS MONONUCLEOSIS: EPSTEIN-BARR VIRUS-INDUCED THROMBOCYTOPENIA THROMBOCYTOPENIA DURING INFECTIOUS MONONUCLEOSIS
1764HTML: 501PDF: 1054 -
BONE MARROW ABONRMALITIES IN HIV INFECTION
1787PDF: 1091HTML: 1724 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1308PDF: 728HTML: 930 -
CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.
3011PDF: 851HTML: 1522Fig.1 CHL-R paper: 186Fig 2 CHL-R paper: 214 -
Severe autoimmune hemolytic anemia in Covid-19 infection Autoimmune hemolytic anemia in Covid-19
3006PDF: 1521HTML: 248 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
3949PDF: 1509HTML: 791 -







